These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 617954)

  • 1. Systemic mastocytosis. Report of a case.
    Bláha M; Kacerovský J; Hrncír Z; Nozicka Z; Spacek J; Siroký O
    Haematologia (Budap); 1977; 11(3-4):349-57. PubMed ID: 617954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urticaria pigmentosa adultorum and systemic mastocytosis--diagnostic principles and therapeutic possibilities].
    Senff H; Kuhlwein A; Reinel D
    Z Hautkr; 1987 Nov; 62(21):1529-30, 1533-6. PubMed ID: 3424899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytosis with urticaria pigmentosa and osteoporosis.
    Stein JA; Kamino H; Walters RF; Pomeranz MK
    Dermatol Online J; 2008 Oct; 14(10):2. PubMed ID: 19061601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
    Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
    Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilia in systemic mastocytosis.
    Yam LT; Yam CF; Li CY
    Am J Clin Pathol; 1980 Jan; 73(1):48-54. PubMed ID: 7352423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
    Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
    Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic mastocytosis with myeloid splenomegaly type hematological manifestations].
    Krulik M; Brivet F; Audebert AA; Curioni S; Debray J
    Ann Med Interne (Paris); 1977 Mar; 128(3):245-53. PubMed ID: 869393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral interstitial keratitis: a novel manifestation of ocular mastocytosis.
    Magone MT; Maric I; Hwang DG
    Cornea; 2006 Apr; 25(3):364-7. PubMed ID: 16633043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic mastocytosis. A clinical, cytological and ultrastructural study].
    Vilaseca J; López Vivancos J; Irriguible MD; Vallespí MT; de Torres IM; Ruiz Marcellán C
    Med Clin (Barc); 1986 Jun; 87(4):156-8. PubMed ID: 3736238
    [No Abstract]   [Full Text] [Related]  

  • 11. Urticaria pigmentosa. Histaminuria and treatment.
    Tabar AI; Vives R; Valcayo A; Montes M; Varela JI
    Allergol Immunopathol (Madr); 1990; 18(2):101-3. PubMed ID: 1973586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].
    Horny HP; Krokowski M; Feller AC; Hintze G; Sotlar K; Valent P
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):222-8. PubMed ID: 12238313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
    Olafsson JH
    Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mastocytosis.
    Korenblat PE; Wedner HJ; Whyte MP; Frankel S; Avioli LV
    Arch Intern Med; 1984 Nov; 144(11):2249-53. PubMed ID: 6208859
    [No Abstract]   [Full Text] [Related]  

  • 15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-1986. A 73-year-old man with diffuse osteosclerotic lesions.
    N Engl J Med; 1986 Sep; 315(13):816-24. PubMed ID: 3748093
    [No Abstract]   [Full Text] [Related]  

  • 16. Portal hypertension in systemic mastocytosis.
    Capron JP; Lebrec D; Degott C; Chivrac D; Coevoet B; Delobel J
    Gastroenterology; 1978 Mar; 74(3):595-7. PubMed ID: 631492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.
    Sucker C; Mansmann G; Steiner S; Gattermann N; Schmitt-Graeff A; Loncar R; Scharf RE; Stockschlader M
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):360-4. PubMed ID: 18160568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous mastocytosis in Thai children.
    Singalavanija S; Limpongsanurak W
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S143-6. PubMed ID: 19253510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.